However, the most important advance in this field was represented by recombinant gene technology (FVIII gene was cloned in 1984 and the first haemophilic patient was infused in 1987) and protein purification techniques, which enabled the development of highly purified recombinant factor VIII (rFVIII) products.

All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional.